Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PLAU | P00749 | 12/20 | 0.55 |
| ▸ | ALDH1A1 | P00352 | 7/20 | 0.47 |
| ▸ | KDM4E | B2RXH2 | 6/20 | 0.47 |
| ▸ | HPGD | P15428 | 6/20 | 0.47 |
| ▸ | HSD17B10 | Q99714 | 6/20 | 0.47 |
| ▸ | GLA | P06280 | 5/20 | 0.47 |
| ▸ | SCNN1A | P37088 | 5/20 | 0.47 |
| ▸ | CYP1A2 | P05177 | 4/20 | 0.47 |
| ▸ | LMNA | P02545 | 3/20 | 0.47 |
| ▸ | CYP2D6 | P10635 | 3/20 | 0.47 |
| ▸ | GAA | P10253 | 3/20 | 0.47 |
| ▸ | FTO | Q9C0B1 | 2/20 | 0.47 |
| ▸ | BLM | P54132 | 2/20 | 0.47 |
| ▸ | SLC22A1 | O15245 | 1/20 | 0.47 |
| ▸ | HTR1A | P08908 | 1/20 | 0.47 |
| ▸ | TSHR | P16473 | 1/20 | 0.47 |
| ▸ | SLC9A1 | P19634 | 1/20 | 0.47 |
| ▸ | MAOA | P21397 | 1/20 | 0.47 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.47 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Trifluoroacetic Acid SCHEMBL5015581 | 0.85 | PLAU (0.46) | PLAUALDH1A1KDM4EHPGDHSD17B10 | |
| SCHEMBL5014171 | 0.83 | SCNN1A (0.52) | PLAUALDH1A1KDM4EHPGDHSD17B10 | |
| SCHEMBL5015580 | 0.79 | ALDH1A1 (0.49) | PLAUALDH1A1KDM4EHPGDHSD17B10 | |
| Benzamil SCHEMBL4242779 | 0.79 | PLAU (0.63) | PLAUALDH1A1KDM4EHPGDHSD17B10 | |
| Benzamil SCHEMBL412783 | 0.79 | PLAU (0.63) | PLAUALDH1A1KDM4EHPGDHSD17B10 | |
| Benzamil SCHEMBL5433990 | 0.79 | PLAU (0.63) | PLAUALDH1A1KDM4EHPGDHSD17B10 | |
| SCHEMBL10028719 | 0.79 | SCNN1A (0.61) | PLAUALDH1A1KDM4EHPGDHSD17B10 | |
| Benzamil SCHEMBL9464171 | 0.78 | PLAU (0.64) | PLAUALDH1A1KDM4EHPGDHSD17B10 | |
| SCHEMBL5065784 | 0.77 | KCNH2 (0.51) | PLAUALDH1A1KDM4EHPGDHSD17B10 | |
| SCHEMBL13165413 | 0.77 | SCNN1A (0.52) | PLAUALDH1A1KDM4EHPGDHSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20080312212-A1 | Organic Compounds | NOVARTIS AG | 2008-12-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080312212-A1 | Organic Compounds | TRPA1, TRPV1, TRPV3 | PLAU 3355/4885ALDH1A1 1322/4885KDM4E 3755/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.